IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Edwards Lifesciences Corp

CUSIP: 208176E11 | 1 institutional holders

Quarters

Q4 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2023

Schroder Investment Management Group2,767
0.0% of portfolio›$211.0K
StyleTurnoverLocationFiled
Schroder Investment Management Group
2,767$211.0K0.0%CoreMediumLondon, United Kingdom2024-02-14